Jefferies Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Jefferies Financial Group's BIO Position: Q3 2026 in Review
Jefferies Financial Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 4,605 shares worth $1.74M. The stake represents 0.01% of the portfolio and ranks #616 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in BIO as recently as Q4 2025.
Jefferies Financial Group first reported a position in BIO in Q4 2022 and has held it in 11 quarters since. The position peaked at $6.95M in Q4 2022. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Jefferies Financial Group held 4,605 shares of Bio-Rad Laboratories Class A worth $1.74M as of Q3 2026.
- Bio-Rad Laboratories Class A was a new Jefferies Financial Group position in Q3 2026.
- Bio-Rad Laboratories Class A made up 0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #616 holding.
- Jefferies Financial Group first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and has held it in 11 quarters since.
- Jefferies Financial Group's Bio-Rad Laboratories Class A position peaked at $6.95M in Q4 2022.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.